445 related articles for article (PubMed ID: 18400425)
1. pH control of nucleophilic/electrophilic oxidation.
Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA
Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425
[TBL] [Abstract][Full Text] [Related]
2. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
Wu Y; Dali M; Gupta A; Raghavan K
Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
[TBL] [Abstract][Full Text] [Related]
3. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
Bao Y; Mo X; Xu X; He Y; Xu X; An H
J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
[TBL] [Abstract][Full Text] [Related]
4. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
Kristensen S; Lao YE; Brustugun J; Braenden JU
Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
[TBL] [Abstract][Full Text] [Related]
5. Persulfate oxidation for in situ remediation of TCE. II. Activated by chelated ferrous ion.
Liang C; Bruell CJ; Marley MC; Sperry KL
Chemosphere; 2004 Jun; 55(9):1225-33. PubMed ID: 15081763
[TBL] [Abstract][Full Text] [Related]
6. A prediction system of oxidation reaction as a solid-state stress condition: applied to a pyrrole-containing pharmaceutical compound.
Kawaguchi-Murakami Y; Fukutsu N; Kajiro T; Araki T; Murakami T; Kawasaki T; Kishi N; Konno M
J Pharm Biomed Anal; 2009 Oct; 50(3):328-35. PubMed ID: 19497698
[TBL] [Abstract][Full Text] [Related]
7. The second step of the nitric oxide synthase reaction: evidence for ferric-peroxo as the active oxidant.
Woodward JJ; Chang MM; Martin NI; Marletta MA
J Am Chem Soc; 2009 Jan; 131(1):297-305. PubMed ID: 19128180
[TBL] [Abstract][Full Text] [Related]
8. Role of iron and hydroperoxides in the degradation of lycopene in oil-in-water emulsions.
Boon CS; McClements DJ; Weiss J; Decker EA
J Agric Food Chem; 2009 Apr; 57(7):2993-8. PubMed ID: 19265448
[TBL] [Abstract][Full Text] [Related]
9. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
[TBL] [Abstract][Full Text] [Related]
10. Stability and degradation profiles of Spantide II in aqueous solutions.
Kikwai L; Babu RJ; Kanikkannan N; Singh M
Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
Zannou EA; Ji Q; Joshi YM; Serajuddin AT
Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation.
Ozyürek M; Bektaşoğlu B; Güçlü K; Apak R
Anal Chim Acta; 2008 Jun; 616(2):196-206. PubMed ID: 18482604
[TBL] [Abstract][Full Text] [Related]
13. Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400.
Kochling JD; Miao H; Young CR; Looker AR; Shannon M; Montgomery ER
J Pharm Biomed Anal; 2007 Apr; 43(5):1638-46. PubMed ID: 17224256
[TBL] [Abstract][Full Text] [Related]
14. Stability of ricobendazole in aqueous solutions.
Wu Z; Tucker IG; Razzak M; Medlicott NJ
J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
[TBL] [Abstract][Full Text] [Related]
15. Ozonation and advanced oxidation by the peroxone process of ciprofloxacin in water.
De Witte B; Dewulf J; Demeestere K; Van Langenhove H
J Hazard Mater; 2009 Jan; 161(2-3):701-8. PubMed ID: 18513860
[TBL] [Abstract][Full Text] [Related]
16. Electron paramagnetic resonance spectroscopy studies of oxidative degradation of an active pharmaceutical ingredient and quantitative analysis of the organic radical intermediates using partial least-squares regression.
Williams HE; Loades VC; Claybourn M; Murphy DM
Anal Chem; 2006 Jan; 78(2):604-8. PubMed ID: 16408946
[TBL] [Abstract][Full Text] [Related]
17. Electrochemical detection of triacetone triperoxide employing the electrocatalytic reaction of iron(II/III)-ethylenediaminetetraacetate and hydrogen peroxide.
Laine DF; Roske CW; Cheng IF
Anal Chim Acta; 2008 Feb; 608(1):56-60. PubMed ID: 18206994
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms.
Tomar RS; Joseph TJ; Murthy AS; Yadav DV; Subbaiah G; Krishna Reddy KV
J Pharm Biomed Anal; 2004 Sep; 36(1):231-5. PubMed ID: 15351071
[TBL] [Abstract][Full Text] [Related]
19. Detailed spectroscopic, thermodynamic, and kinetic studies on the protolytic equilibria of Fe(III)cydta and the activation of hydrogen peroxide.
Brausam A; Maigut J; Meier R; Szilágyi PA; Buschmann HJ; Massa W; Homonnay Z; van Eldik R
Inorg Chem; 2009 Aug; 48(16):7864-84. PubMed ID: 19618946
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous catalytic wet peroxide oxidation systems for the treatment of an industrial pharmaceutical wastewater.
Melero JA; Martínez F; Botas JA; Molina R; Pariente MI
Water Res; 2009 Sep; 43(16):4010-8. PubMed ID: 19447465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
